- Fresenius Medical Care enters virtual power purchase agreements
for renewable energy to clearly step forward in reducing
CO2 emissions footprint
- Company enacts five virtual power purchase agreements for
around 580 gigawatt hours per year with wind and solar farms in
Germany and the U.S.
- Energy farms scheduled to go into operation in 2024 and
2025
- Important milestone for strategic sustainability goal to
achieve climate-neutrality by 2040
BAD HOMBURG, Germany, June 12,
2024 /PRNewswire/ -- Fresenius Medical Care (FME),
the world's leading provider of products and services for people
with kidney disease, has signed five virtual power purchase
agreements (vPPAs) with wind and solar energy project developers in
Germany and the U.S. The projects
are expected to feed around 580 gigawatt hours of renewable energy
into the grid, which equals up to 46 percent of FME's most recently
reported global consumption. The company is thus taking an
important step towards its goal of reducing emissions in its own
operations (Scope 1 and 2) by 50 percent by 2030.
"The commitment to sustainability is firmly anchored in our
corporate mission with the objective to become carbon neutral in
our operations by 2040," says Helen
Giza, CEO of Fresenius Medical Care AG. "The successful
execution of the agreements is an important milestone and brings us
closer to this goal."
Wind and solar power are generated from five energy projects as
part of the vPPAs. The wind and solar parks are scheduled to go
into operation in 2024 and 2025, and the contracts with FME have
terms of 10 to 15 years.
Fresenius Medical Care has continuously expanded its global
sustainability activities in recent years. The focus is on three
strategic focus areas:
- enhancing quality of care and access to healthcare,
- building the best team to serve patients and
- reducing the company's environmental footprint.
In January 2024, FME also
submitted the commitment letter for the Science Based Target
initiative (SBTi), further aligning its climate targets with the
SBTi standards. At this year's Annual General Meeting, the
reduction of greenhouse gas emissions was also anchored as a
performance target for the long-term variable remuneration of the
Management Board in the new 2024+ remuneration system.
About Fresenius Medical Care:
Fresenius Medical Care is the world's leading provider of
products and services for individuals with renal diseases of which
around 4.1 million patients worldwide regularly undergo dialysis
treatment. Through its network of 3,862 dialysis clinics, Fresenius
Medical Care provides dialysis treatments for approx. 325,000
patients around the globe. Fresenius Medical Care is also the
leading provider of dialysis products such as dialysis machines or
dialyzers. Fresenius Medical Care is listed on the Frankfurt Stock
Exchange (FME) and on the New York Stock Exchange (FMS).
For more information visit the Company's website
at www.freseniusmedicalcare.com.
Disclaimer:
This release contains forward-looking statements that are subject
to various risks and uncertainties. Actual results could differ
materially from those described in these forward-looking statements
due to various factors, including, but not limited to, changes in
business, economic and competitive conditions, legal changes,
regulatory approvals, impacts related to the COVID-19 pandemic
results of clinical studies, foreign exchange rate fluctuations,
uncertainties in litigation or investigative proceedings, and the
availability of financing. These and other risks and uncertainties
are detailed in Fresenius Medical Care's reports filed with the
U.S. Securities and Exchange Commission. Fresenius Medical Care
does not undertake any responsibility to update the forward-looking
statements in this release.
Media Contact
Christine
Peters
T +49 160 60 66
770
christine.peters@freseniusmedicalcare.com
Sabine
Blessing
T +49 171 74 81
259
sabine.blessing@freseniusmedicalcare.com
Contact for Analysts and
Investors
Dr. Dominik
Heger
T +49 6172 609
2601
dominik.heger@freseniusmedicalcare.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fresenius-medical-care-takes-next-important-step-towards-goal-to-reduce-co2-emissions-in-its-operations-302170117.html
SOURCE Fresenius Medical Care Holdings, Inc.